ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
0,746
-0,013
( -1,71% )
Aktualisiert: 16:16:49

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,746
Gebot
0,744
Fragen
0,754
Volumen
22.840
0,746 Tagesbereich 0,79
0,656 52-Wochen-Bereich 1,52
Marktkapitalisierung
Handelsende
0,759
Handelsbeginn
0,79
Letzte Trade
285
@
0.746
Letzter Handelszeitpunkt
16:16:49
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
33.987
Ausgegebene Aktien
100.852.742
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,39
Gewinn pro Aktie (EPS)
-0,22
Erlöse
7,9M
Nettogewinn
-22,33M

Über Transgene SA

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Illkirch-graffenstaden, Bas-rhin, Fra
Gegründet
-
Transgene SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker TNG. The last closing price for Transgene was 0,76 €. Over the last year, Transgene shares have traded in a share price range of 0,656 € to 1,52 €.

Transgene currently has 100.852.742 shares in issue. The market capitalisation of Transgene is 76,55 € million. Transgene has a price to earnings ratio (PE ratio) of -3.39.

TNG Neueste Nachrichten

Bilan du Contrat de Liquidité avec la Société Natixis Oddo BHF SCA au 31 décembre 2024

Bilan du Contrat de Liquidité avec la Société Natixis Oddo BHF SCA au 31 décembre 2024 Strasbourg, le 7 janvier 2025 – 18h00 Au titre du contrat de liquidité confié par Transgene à Natixis Oddo...

Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2024

Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2024 Strasbourg, January 7, 2025 – 06:00 pm CET Under the liquidity contract entrusted by Transgene to Natixis...

Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024

Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024 Les données de...

Transgene Reports Business, Pipeline and Financial Update for Q3 2024

Transgene Reports Business, Pipeline and Financial Update for Q3 2024 TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck...

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024 Compelling 24.1-month median follow-up data...

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant standard of care remain disease-free TG4050 induced...

Transgene fait le point sur ses activités, son portefeuille et sa situation financière au troisième trimestre 2024

Transgene fait le point sur ses activités, son portefeuille et sa situation financière au troisième trimestre 2024 TG4050 : Données prometteuses de Phase I présentées au SITC 2024 confirmant une...

Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés

Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés Strasbourg (France), Berlin (Germany), le 5 novembre 2024, 7 h 30 Transgene...

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development

Strasbourg (France), Berlin (Germany), November 5, 2024, 7:30 a.m. CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0639.224011713030.6830.790.68572000.75455299DE
40.0294.044630404460.7170.790.656308030.73004306DE
12-0.258-25.69721115541.0041.0040.656339870.8066339DE
26-0.354-32.18181818181.11.210.656304380.94646204DE
52-0.614-45.14705882351.361.520.656310241.10257879DE
156-1.744-70.04016064262.492.7750.656346591.77310941DE
260-0.836-52.84450063211.5823.150.656716061.9694612DE

TNG - Frequently Asked Questions (FAQ)

What is the current Transgene share price?
The current share price of Transgene is 0,746 €
How many Transgene shares are in issue?
Transgene has 100.852.742 shares in issue
What is the market cap of Transgene?
The market capitalisation of Transgene is EUR 76,55M
What is the 1 year trading range for Transgene share price?
Transgene has traded in the range of 0,656 € to 1,52 € during the past year
What is the PE ratio of Transgene?
The price to earnings ratio of Transgene is -3,39
What is the cash to sales ratio of Transgene?
The cash to sales ratio of Transgene is 9,58
What is the reporting currency for Transgene?
Transgene reports financial results in EUR
What is the latest annual turnover for Transgene?
The latest annual turnover of Transgene is EUR 7,9M
What is the latest annual profit for Transgene?
The latest annual profit of Transgene is EUR -22,33M
What is the registered address of Transgene?
The registered address for Transgene is 400 BOULEVARD GONTHIER D’ANDERNACH-PARC D'INNOVATION, ILLKIRCH-GRAFFENSTADEN, BAS-RHIN, 67405
What is the Transgene website address?
The website address for Transgene is www.transgene.fr
Which industry sector does Transgene operate in?
Transgene operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
HYPDSHipay Group DS
0,0024 €
(200,00%)
1,83k
BNBSTonner Drones
0,0015 €
(50,00%)
100
ALLPLLepermislibre SA
0,56 €
(40,00%)
16,42k
MLAZRThe Azur Selection SA
1,18 €
(18,00%)
74,27k
MLEFAEduformAction
0,398 €
(17,06%)
579
ALALOAcheterLouerFR
0,09 €
(-18,18%)
111,09k
ALTHETheraclion
0,232 €
(-17,14%)
32,91k
NYRNyrstar NV
0,0732 €
(-11,81%)
50,69k
MLBONBonyf NV
15,90 €
(-11,67%)
105
TDBSTonner Drones
0,0008 €
(-11,11%)
6,18M
ATOAtos SE
0,0022 €
(10,00%)
1,67B
BCPBanco Comercial Portugues SA
0,4779 €
(-0,48%)
33,87M
ALVERVergnet
0,0017 €
(-5,56%)
18,84M
ALCYBCybergun
0,0001 €
(0,00%)
16,27M
INGAING Groep NV
15,436 €
(2,50%)
7,98M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock